Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells

被引:84
作者
Charbonnier, Louis-Marie
van Duivenvoorde, Leonie M.
Apparailly, Florence
Cantos, Celine
Han, Wanda G. H.
Noel, Daniele
Duperray, Christophe
Huizinga, Tom W. J.
Toes, Rene E. M.
Jorgensen, Christian
Louis-Plence, Pascale
机构
[1] INSERM, U475, F-34197 Montpellier 05, France
[2] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[3] Ctr Hosp Univ, Hop Lapeyronie, Unite Clin Immunorhumatol Therapeut Malad Articul, Montpellier, France
[4] Univ Montpellier 1, Montpellier, France
关键词
D O I
10.4049/jimmunol.177.6.3806
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) are specialized APCs with an important role in the initiation and regulation of immune responses. Immature DCs (iDCs) reportedly mediate tolerance in the absence of maturation/inflammatory stimuli, presumably by the induction of regulatory T cells. In this study, we show for the first time that repetitive iDC injections trigger the expansion of a novel regulatory population with high immunomodulatory properties, able to protect mice from collagen-induced arthritis. These regulatory T cells are characterized by the expression of the CD49b molecule and correspond to a CD4(+) alpha-galactosylceramide/CD1d-nonrestricied T cell population producing IL-10. Adoptive transfer of < 10(5) TCR beta(+)CD49b(+) cells isolated from the liver of iDCs-vaccinated mice, conferred a complete protection against arthritis. This protection was associated with an attenuation of the B and T cell response associated with a local secretion of IL-10. Thus, together these data demonstrate that iDCs can expand and activate a novel regulatory population of CD49b(+) T cells, with high immunosuppressive potential able to mediate protection against a systemic autoimmune disease.
引用
收藏
页码:3806 / 3813
页数:8
相关论文
共 26 条
[1]   Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen [J].
Akbari, O ;
DeKruyff, RH ;
Umetsu, DT .
NATURE IMMUNOLOGY, 2001, 2 (08) :725-731
[2]  
Apparailly F, 1998, J IMMUNOL, V160, P5213
[3]   Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells [J].
Dhodapkar, MV ;
Steinman, RM ;
Krasovsky, J ;
Munz, C ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :233-238
[4]   Immunotherapy of NOD mice with bone marrow-derived dendritic cells [J].
Feili-Hariri, M ;
Dong, X ;
Alber, SM ;
Watkins, SC ;
Salter, RD ;
Morel, PA .
DIABETES, 1999, 48 (12) :2300-2308
[5]   Damage control, rather than unresponsiveness, effected by protective DX5+T cells in autoimmune diabetes [J].
Gonzalez, A ;
Andre-Schmutz, I ;
Carnaud, C ;
Mathis, D ;
Benoist, C .
NATURE IMMUNOLOGY, 2001, 2 (12) :1117-1125
[6]   Designer dendritic cells for tolerance induction: guided not misguided missiles [J].
Hackstein, H ;
Morelli, AE ;
Thomson, AW .
TRENDS IN IMMUNOLOGY, 2001, 22 (08) :437-442
[7]   CD1d-restricted NKT cells: An interstrain comparison [J].
Hammond, KJL ;
Pellicci, DG ;
Poulton, LD ;
Naidenko, OV ;
Scalzo, AA ;
Baxter, AG ;
Godfrey, DI .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1164-1173
[8]   The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice [J].
Hong, S ;
Wilson, MT ;
Serizawa, I ;
Wu, L ;
Singh, N ;
Naidenko, OV ;
Miura, T ;
Haba, T ;
Scherer, DC ;
Wei, J ;
Kronenberg, M ;
Koezuka, Y ;
Van Kaer, L .
NATURE MEDICINE, 2001, 7 (09) :1052-1056
[9]   Control of regulatory T cell development by the transcription factor Foxp3 [J].
Hori, S ;
Nomura, T ;
Sakaguchi, S .
SCIENCE, 2003, 299 (5609) :1057-1061
[10]   GENERATION OF LARGE NUMBERS OF DENDRITIC CELLS FROM MOUSE BONE-MARROW CULTURES SUPPLEMENTED WITH GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR [J].
INABA, K ;
INABA, M ;
ROMANI, N ;
AYA, H ;
DEGUCHI, M ;
IKEHARA, S ;
MURAMATSU, S ;
STEINMAN, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1693-1702